KDR and cancer: For example, the vascular endothelial growth factor receptor 2 (VEGFR2), which is a molecular marker of angiogenesis and is overexpressed on tumor vascular endothelial cells, is widely used in preclinical cancer research as a marker of therapy responsiveness [88,89,90,91,92].